Sign Up to like & get
recommendations!
2
Published in 2023 at "Advanced materials"
DOI: 10.1002/adma.202211420
Abstract: Lipid nanoparticles (LNPs) are clinically proven to successfully deliver both small interfering RNA (siRNA) therapeutics and larger mRNA payloads for prophylactic vaccine applications. Non-human primates (NHPs) are generally considered to be the most predictive of…
read more here.
Keywords:
nanoparticles delivery;
potency;
optimizing lipid;
delivery primates ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Advanced materials"
DOI: 10.1002/adma.202303261
Abstract: Messenger RNA (mRNA) has received great attention in the prevention and treatment of various diseases due to the success of COVID-19 mRNA vaccines (Comirnaty and Spikevax). To meet the therapeutic purpose, it is required that…
read more here.
Keywords:
nanoparticle lnp;
lnp;
therapy;
lipid nanoparticle ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Macromolecular bioscience"
DOI: 10.1002/mabi.202200423
Abstract: In this study, a novel polyhistidine (pHis)-incorporated lipid nanoparticle (pHis/LNP) was developed for the delivery of therapeutic globotriaosylceramide (Gb3) synthase siRNAs using a microfluidic device with pHis as a biocompatible method of endosome escape. To…
read more here.
Keywords:
synthase;
gb3 synthase;
phis lnp;
lnp ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "World Journal of Surgery"
DOI: 10.1007/s00268-019-05302-6
Abstract: Introduction We investigated outcomes in a cohort of patients with a biochemical diagnosis of primary hyperparathyroidism (pHPT) undergoing surgery for asymptomatic disease or target organ damage, where a focussed or four-gland operation was undertaken and…
read more here.
Keywords:
large normal;
primary hyperparathyroidism;
lnp;
phpt ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cell Research"
DOI: 10.1038/s41422-022-00630-0
Abstract: Monoclonal antibodies represent important weapons in our arsenal to against the COVID-19 pandemic. However, this potential is severely limited by the time-consuming process of developing effective antibodies and the relative high cost of manufacturing. Herein,…
read more here.
Keywords:
sars cov;
protection sars;
antibody;
lnp ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-123709
Abstract: Background: NUP98-NSD1 positive AML is a poor prognostic subgroup within pediatric and adult AML (Thol et al., 2013). However, targeted therapeutics for these AML patients are not available to date. As a result of the…
read more here.
Keywords:
nup98 nsd1;
treatment;
lnp;
fusion ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS Pathogens"
DOI: 10.1371/journal.ppat.1010830
Abstract: Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been administered to humans. However, we lack a comprehensive understanding of the immune effects of this platform. The mRNA-LNP-based SARS-CoV-2 vaccine is highly inflammatory, and…
read more here.
Keywords:
exposure mrna;
lnp;
pre exposure;
adaptive immune ... See more keywords